Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2018 | 10-2017 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 11 | 3 |
| Receivables | 886 | 1,339 |
| Inventories | 95 | 0 |
| TOTAL | $1,045 | $1,392 |
| Non-Current Assets | ||
| PPE Net | 310 | 333 |
| Investments And Advances | N/A | 5 |
| Intangibles | 1,984 | 1,671 |
| Other Non-Current Assets | 47 | 0 |
| TOTAL | $2,341 | $2,008 |
| Total Assets | $3,385 | $3,400 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 946 | 980 |
| Accounts payable and accrued liabilities | 1,559 | 1,049 |
| Accrued Expenses | 407 | 206 |
| TOTAL | $3,052 | $2,292 |
| Non-Current Liabilities | ||
| Long Term Debt | 1,460 | 3,463 |
| Other Non-Current Liabilities | 241 | 247 |
| TOTAL | $1,701 | $3,710 |
| Total Liabilities | $4,753 | $6,002 |
| Shareholders' Equity | ||
| Common Shares | 4,659 | 413 |
| Retained earnings | -6,101 | -3,019 |
| Other shareholders' equity | -192 | -186 |
| TOTAL | $-1,368 | $-2,603 |
| Total Liabilities And Equity | $3,385 | $3,400 |